Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Cytek Biosciences hits flow cytometry milestone: 40 color analysis from a single sample

Flow cytometry’s next chapter is here. Opening the door to deeper immunological insights, Cytek Biosciences Inc., a leading provider of flow cytometry instrumentation, today announced that it has successfully developed and demonstrated a high-quality 40-color panel from a single sample using the Cytek® Aurora advanced flow cytometry system.

From Cytek Biosciences 5 Oct 2019

Targeting HDAC2 reduces MDM2 expression and has anti-tumor effects in dedifferentiated liposarcoma

The cover for issue 55 of Oncotarget features Figure 3, "Romidepsin exhibits anti-tumor effect in xenograft model of DDLPS," by Seligson, et al.

4 Oct 2019

HIV-1 Tat expression leads to perturbations in cellular protein expression, research suggests

The cover for issue 54 of Oncotarget features Figure 2, "Comparative proteomic profiling of the peptides/proteins identified from 293T, IL16lamp2b and mExo-Tat samples," by Lu, et al.

4 Oct 2019

Cytek Biosciences' flow cytometry system achieves 40 color analysis from a single sample

From Cytek Biosciences 4 Oct 2019

Patients would like to be asked before using medical data for research

With electronic medical records creating an ideal source of data to inform quality care and new discovery, a key question emerges: How much say should patients have in how their data is used?

4 Oct 2019

Women with breast cancer face very unique challenges

Will I be able to have a baby? Will the treatment trigger early menopause? What about my sex life? Women under 40 who are diagnosed with breast cancer face some very unique challenges.

3 Oct 2019

Multi-gene testing at point of diagnosis can save all women with breast cancer

A lifetime model evaluating the financial, health and social impact of multi-gene testing (BRCA1/2/PALB2) at diagnosis for all breast cancer patients was found to be extremely cost effective for both UK and US health systems.

3 Oct 2019

Researchers discover metabolic vulnerability in cancer cells with mutated spliceosomes

A research team from the Johns Hopkins Kimmel Cancer Center reports it has discovered a metabolic vulnerability in multiple types of cancer cells that bear a common genetic mutation affecting cellular machines called spliceosomes.

From Johns Hopkins Medicine 3 Oct 2019

Quanterix announces recipients of annual Accelerator Grant Program

Quanterix Corporation, a company digitizing biomarker analysis to advance the science of precision health, today announced Shelli Kesler, Ph.

From Quanterix 3 Oct 2019

Walmart to give workers financial incentives to use higher-quality doctors

Worried its employees aren't getting good enough care from doctors in their insurance networks, Walmart next year will test pointing workers in northwestern Arkansas, central Florida and the Dallas-Fort Worth area toward physicians it has found provide better service.

3 Oct 2019

New 3D scaffold may help identify the best treatments for cancer

A new 3D structure for growing cell cultures could enable doctors to test medications on model tumors grown from a patient's own cells, according to results from a team of engineers and cancer researchers at the University of Michigan.

3 Oct 2019

New algorithm can help reduce therapy for some patients with intermediate-risk neuroblastoma

A recent Children's Oncology Group study identified a treatment algorithm that can help reduce therapy for some neuroblastoma patients with intermediate-risk disease, while maintaining good clinical outcomes.

2 Oct 2019

Targeted therapy slows disease progression and improves survival for prostate cancer

A new PARP-inhibitor has been shown to significantly delayed cancer progression among patients with prostate cancer who had cancer cells with faulty DNA repair genes.

2 Oct 2019

The Slaight Family Foundation supports UHN to deliver enhanced care for seniors outside the hospital

The Silver Tsunami will see an unprecedented number of seniors in Canada, which is also true throughout North America.

1 Oct 2019

Detecting neurocognitive change in children with acute lymphoblastic leukemia

Although cure rates for children with cancer are increasing, cancer treatments can cause permanent deterioration of brain functions leading to impairments in attention, concentration, memory and learning. As a result, these changes can lead to challenges with school, obtaining future employment and overall quality of life into adulthood, even though cancer treatment may have been successful.

1 Oct 2019

Johns Hopkins Medicine celebrates opening of Pavilion III at Green Spring Station

As part of an $80 million expansion at Green Spring Station, Johns Hopkins Medicine celebrated the official opening of the newly built Pavilion III at Green Spring Station with a private grand opening event on Sept. 27 and a free community health fair on Sept. 28.

1 Oct 2019

Oncology News and Research

Further Reading

Cytek Biosciences hits flow cytometry milestone: 40 color analysis from a single sample

Targeting HDAC2 reduces MDM2 expression and has anti-tumor effects in dedifferentiated liposarcoma

HIV-1 Tat expression leads to perturbations in cellular protein expression, research suggests

Cytek Biosciences' flow cytometry system achieves 40 color analysis from a single sample

Patients would like to be asked before using medical data for research

Women with breast cancer face very unique challenges

Multi-gene testing at point of diagnosis can save all women with breast cancer

Researchers discover metabolic vulnerability in cancer cells with mutated spliceosomes

Quanterix announces recipients of annual Accelerator Grant Program

Walmart to give workers financial incentives to use higher-quality doctors

New 3D scaffold may help identify the best treatments for cancer

New algorithm can help reduce therapy for some patients with intermediate-risk neuroblastoma

Targeted therapy slows disease progression and improves survival for prostate cancer

The Slaight Family Foundation supports UHN to deliver enhanced care for seniors outside the hospital

Detecting neurocognitive change in children with acute lymphoblastic leukemia

Johns Hopkins Medicine celebrates opening of Pavilion III at Green Spring Station

UC experts explore if ketogenic diet could help make treatments for glioblastoma

Modern chemo more effective than second targeted hormone therapy against resistant prostate cancer

Breast, ovarian cancer drug more effective than targeted hormone therapy in some men with prostate cancer

Intensive new combination therapy for ovarian cancer shows promising results

Event guide: The 9th DDR Inhibitors Summit 2026 eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News